Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Nicolas Barthelemy, Richard Ding, Bruce Bodaken, Karin Eastham, Jorge Garces

Premium

BioTheranostics Nicolas Barthelemy its new president and CEO. He succeeds Richard Ding, who will remain chairman of the board of bioTheranostics in addition to heading the Asia Pacific operations for parent company bioMérieux. Barthelemy previously served as chief commercial officer and president of the Cell Systems Division.


AltheaDx announced the appointment of Bruce Bodaken, Karin Eastham, and Jorge Garces its board of directors.

Bodaken served as chairman and CEO of Blue Shield of California from January 2000 to December 2012, and currently serves on the boards of directors of Rite Aid and WageWorks. He also is on the board of directors of the Institute of Medicine's Roundtable on Value and Science-Driven Healthcare, and is a visiting scholar at the Brookings Institution.

Eastham serves on the boards of directors of lllumina, Veracyte, MorphoSys, and Geron. She previously was executive VP, COO, and a member of the board of trustees of the Burnham Institute for Medical Research.

Garces has been president of AltheaDx since February 2014 and the firm's COO since June 2013. Prior to joining AltheaDx, he was senior VP of R&D at GenMark Diagnostics, CEO and president of Enigma Diagnostics, and VP and site operations manager of Hologic.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.